INS and cancer: 2019; Luo et al. 2023), Jingguo Li’s team develops nanomedicine materials incorporating celastrol (Li et al. 2015; An et al. 2020), and Denghai Zhang’s team explores mechanisms for treating chronic diseases such as cancer, Alzheimer’s (Cao et al. 2018), and insulin resistance (Zhang et al. 2018).